ARK Investment Management’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Hold
0
195
2024
Q3
Sell
-2,936,063
Closed -$17.1M 196
2024
Q2
$14.3M Sell
2,936,063
-3,104,413
-51% -$19.5M 0.13% 83
2024
Q1
$80.2M Sell
6,040,476
-984,640
-14% -$13.1M 0.56% 35
2023
Q4
$97.9M Buy
7,025,116
+1,824,549
+35% +$22.6M 0.58% 33
2023
Q3
$69M Buy
5,200,567
+49,716
+1% +$801K 0.53% 35
2023
Q2
$96.6M Buy
5,150,851
+668,760
+15% +$11.1M 0.64% 32
2023
Q1
$64.6M Buy
4,482,091
+116,261
+3% +$2.28M 0.44% 36
2022
Q4
$84.5M Buy
4,365,830
+971,971
+29% +$25.8M 0.73% 26
2022
Q3
$117M Buy
3,393,859
+1,359,735
+67% +$43.4M 0.81% 28
2022
Q2
$30.8M Buy
2,034,124
+347,179
+21% +$5.38M 0.18% 74
2022
Q1
$38.5M Buy
1,686,945
+287,400
+21% +$8.21M 0.16% 79
2021
Q4
$51.6M Buy
1,399,545
+131,840
+10% +$5.54M 0.16% 85
2021
Q3
$59.6M Buy
1,267,705
+719,316
+131% +$42.3M 0.14% 103
2021
Q2
$33M Buy
+548,389
New +$22.8M 0.06% 149

Other funds holding VERV